Skip to content

Efficacy and Safety of Prunus Mume Extract on Improvement of Constipation

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01734226
Enrollment
60
Registered
2012-11-27
Start date
2012-08-31
Completion date
2012-12-31
Last updated
2012-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Brief summary

The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Prunus Mume Extract on Improvement of Constipation. The investigators measured Improvement of Constipation parameters , including Colonic Transit Time, number of bowel movement, defecation time, stool type, color and stool amounts per defecation, and monitored their blood pressure.

Interventions

DIETARY_SUPPLEMENTPrunus Mume Extract

Prunus Mume Extract (3.94g/day)

DIETARY_SUPPLEMENTPlacebo

Placebo (3.94g/day)

Sponsors

Chonbuk National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females 19-40 years old * Subject who have functional constipation by ROME IIII criteria * Subject who have over 36 hour colonic transit time * Able to give informed consent

Exclusion criteria

* Subject who have Irritable bowel syndrome by ROME IIII criteria * Allergic or hypersensitive to any of the ingredients in the test products * History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery * History of alcohol or substance abuse * Participation in any other clinical trials within past 2 months * Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study * Pregnant or lactating women etc.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Colonic Transit Time8 weeksColonic Transit Time was measured in study visit 1(0 week) and visit 3(8 week).
Changes in number of bowel movement8 weeksNumber of bowel movement was measured in study visit 1(0 week) and visit 3(8 week).
Changes in defecation time8 weeksDefecation time was measured in study visit 1(0 week) and visit 3(8 week).

Secondary

MeasureTime frameDescription
Changes in stool type8 weeksStool type was measured in study visit 1(0 week) and visit 3(8 week).
Changes in stool color8 weeksStool color was measured in study visit 1(0 week) and visit 3(8 week).
Changes in stool amounts per defecation8 weeksStool amounts per defecation was measured in study visit 1(0 week) and visit 3(8 week).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026